The Journal of infection · 2026
Real-world effectiveness of influenza vaccination amongst children aged under 5 in a tropical setting.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Wee Liang En, Ho Reen Wan Li, Lim Jue Tao, Lim Soon Kok, Chiew Calvin, Li Russell Jingxian, Li Jiahui, Yung Chee-Fu, Chong Chia Yin, Lee Vernon, Lye David Chien Boon, Tan Kelvin Bryan
Аннотация
OBJECTIVES: Information on influenza vaccine-effectiveness amongst children in tropical regions with year-round influenza transmission remains scarce. We evaluated real-world influenza vaccine-effectiveness in a tropical setting amongst children aged under 5.
METHODS: Population-based retrospective cohort study, including all Singaporean children aged under 5, from 1st May 2022-30th April 2024. Person-time was divided into vaccinated (<365 days prior) and unvaccinated categories (no prior vaccination/vaccinated≥365 days prior). Vaccination was classified using national registries. Overlap-weighted Cox regression was utilised to evaluate hazards-ratio (HR) of influenza hospitalisation between vaccinated/unvaccinated groups; vaccine-effectiveness was calculated as 1-HR. Waning of protection in vaccinated children was evaluated via logistic regression, using weeks 2-9 post-vaccination as reference.
RESULTS: 196,593 children contributed 137,758 vaccinated and 245,952 unvaccinated observations over 80,839,605 person-days. Overall vaccine-effectiveness was 53% (95%CI=44%-60%). However, relative-vaccine-effectiveness (rVE) waned to 21% of baseline (95%CI=12-36%) by weeks 39-52 post-vaccination. In vaccine-naïve individuals, rVE declined to 11%(95%CI=3-36%) of baseline at weeks 39-52 following a single vaccine dose, whereas rVE declined to 13%(95%CI=4-43%) of baseline at weeks 39-52 after two-dose primary vaccination.
CONCLUSION: Vaccination conferred real-world protection amongst children aged under 5 in a tropical setting; though protection waned rapidly. Benefit of a two-dose primary-series might be more marginal in tropical settings.
METHODS: Population-based retrospective cohort study, including all Singaporean children aged under 5, from 1st May 2022-30th April 2024. Person-time was divided into vaccinated (<365 days prior) and unvaccinated categories (no prior vaccination/vaccinated≥365 days prior). Vaccination was classified using national registries. Overlap-weighted Cox regression was utilised to evaluate hazards-ratio (HR) of influenza hospitalisation between vaccinated/unvaccinated groups; vaccine-effectiveness was calculated as 1-HR. Waning of protection in vaccinated children was evaluated via logistic regression, using weeks 2-9 post-vaccination as reference.
RESULTS: 196,593 children contributed 137,758 vaccinated and 245,952 unvaccinated observations over 80,839,605 person-days. Overall vaccine-effectiveness was 53% (95%CI=44%-60%). However, relative-vaccine-effectiveness (rVE) waned to 21% of baseline (95%CI=12-36%) by weeks 39-52 post-vaccination. In vaccine-naïve individuals, rVE declined to 11%(95%CI=3-36%) of baseline at weeks 39-52 following a single vaccine dose, whereas rVE declined to 13%(95%CI=4-43%) of baseline at weeks 39-52 after two-dose primary vaccination.
CONCLUSION: Vaccination conferred real-world protection amongst children aged under 5 in a tropical setting; though protection waned rapidly. Benefit of a two-dose primary-series might be more marginal in tropical settings.